Biote Corp. BTMD Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $188.16M-5.6% | $192.22M-2.5% | $195.65M+1.3% | $199.07M+6.3% | $199.38M+6.4% | ||
| $56.23M-1.8% | $54.86M-5.6% | $54.06M-6.9% | $55.8M-2.1% | $57.29M-0.3% | ||
| $131.93M-7.1% | $137.36M-1.2% | $141.58M+4.9% | $143.27M+10.0% | $142.09M+9.4% | ||
| 70.1%-1.2pp | 71.5%+0.9pp | 72.4%+2.5pp | 72%+2.4pp | 71.3%+1.9pp | ||
| $102.91M-7.5% | $101.81M-5.2% | $110.09M+9.4% | $107.87M+7.3% | $111.22M+12.7% | ||
| $29.03M-6.0% | $35.55M+12.5% | $31.49M-8.3% | $35.41M+18.9% | $30.87M-1.1% | ||
| 15.4%-0.1pp | 18.5%+2.5pp | 16.1%-1.7pp | 17.8%+1.9pp | 15.5%-1.2pp | ||
| -$10.03M+18.1% | -$10.96M+0.4% | -$11.71M-25.7% | -$12.52M-71.3% | -$12.25M-92.0% | ||
| —— | —— | -$728K— | $2.76M— | -$9.08M— | ||
| $23.47M— | $37.58M— | —— | —— | —— | ||
| $5.03M— | $5.99M— | —— | —— | —— | ||
| $15.6M-25.8% | $27.05M+757% | $28.79M+301% | $31.31M+680% | $21.04M+253% | ||
| 8.3%-2.3pp | 14.1%+12.5pp | 14.7%+11.0pp | 15.7%+13.6pp | 10.6%+7.4pp | ||
| $0.44-26.7% | $0.75+582% | $0.80+150% | $0.91+296% | $0.60+216% | ||
| $0.49-27.9% | $0.86+617% | $0.91+176% | $0.99+312% | $0.68+240% | ||
| 141.1M+3.3% | 142.1M+5.8% | 139.7M+11.2% | 135.2M+8.7% | 136.6M+21.8% | ||
| 124.9M-3.8% | 125.7M-5.5% | 128.7M+3.4% | 128.4M+3.8% | 129.9M+16.6% | ||
| $4.48M+41.4% | $13.02M+166% | $11M— | $15.29M— | $3.17M— | ||
| -$10.03M+18.1% | -$10.96M+0.4% | -$11.71M-25.7% | -$12.52M-71.3% | -$12.25M-92.0% | ||
| $18.45M-14.6% | $31.6M+101,845% | $32.46M— | $35.9M— | $21.59M— | ||
| $12K+167% | $6K+140% | $0— | -$8K— | -$18K— | ||
| -$16K-220% | -$29K-364% | -$12K-100% | -$9K0.0% | -$5K+54.5% | ||
| $188.16M-5.6% | $192.22M-2.5% | $195.65M+1.3% | $199.07M+6.3% | $199.38M+6.4% | ||
| $29.03M-6.0% | $35.55M+12.5% | $31.49M-8.3% | $35.41M+18.9% | $30.87M-1.1% | ||
| $32.82M-5.0% | $39.22M+11.5% | $35.35M-7.7% | $39.12M+17.4% | $34.56M+0.4% | ||
| $32.82M-5.0% | $39.22M+11.5% | $35.35M-7.7% | $39.12M+17.4% | $34.56M+0.4% | ||
| 17.4%+0.1pp | 20.4%+2.6pp | 18.1%-1.8pp | 19.7%+1.9pp | 17.3%-1.0pp | ||
| $29.03M-6.0% | $35.55M+12.5% | $31.49M-8.3% | $35.41M+18.9% | $30.87M-1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biote Corp.'s revenue?
- Biote Corp. (BTMD) generated $188.2M in revenue over the trailing twelve months, down 5.6% year over year.
- Is Biote Corp. profitable?
- Biote Corp. reported $15.6M in net income over the trailing twelve months, a 8.3% net margin.
- What are Biote Corp.'s profit margins?
- Gross margin is 70.1% and operating margin is 15.4%, with a 8.3% net margin.
- What is Biote Corp.'s earnings per share?
- Biote Corp.'s diluted EPS over the trailing twelve months is $0.44.
- Where does Biote Corp.'s income statement data come from?
- Every line is extracted from Biote Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
